Prosper Junior Bakiny
TMFPBakiny
Prosper Junior Bakiny is a contributing Motley Fool healthcare analyst covering biotechnology, pharmaceuticals, and healthcare stocks. Before The Motley Fool, Prosper wrote about investing topics ranging from stock market news to private equity for various companies. He holds a master’s degree in corporate finance from the University of Maryland Global Campus.
Recent Articles by Prosper Junior Bakiny
Feb 7, 2025
by Prosper Junior Bakiny
Is CVS Health's Dividend Safe?
Feb 5, 2025
by Prosper Junior Bakiny
2 Monster Stocks to Buy and Hold Forever
Feb 3, 2025
by Prosper Junior Bakiny
The Best Stock to Invest in With $500
Feb 2, 2025
by Prosper Junior Bakiny
Is Johnson & Johnson Stock a Buy?
Jan 26, 2025
by Prosper Junior Bakiny
Where Will Tilray Brands Be in 5 Years?
Jan 23, 2025
by Prosper Junior Bakiny
Can This Beaten-Down Stock Bounce Back in 2025?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.